Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Verónica Briz"'
Autor:
Pedro Lopez-Lopez, Antonio Rivero-Juárez, Mónica Santín, Alejandro Dashti, Begoña Bailo, Javier Caballero-Gómez, David Carmena, Verónica Briz, Pamela C. Köster, Mario Frías‐Casas, Rafael Calero-Bernal
Publikováno v:
Transboundary and Emerging Diseases. 67:2869-2880
Microsporidia is a phylum of obligate emergent intracellular protist-like fungi pathogens that infect a broad range of hosts including vertebrates and invertebrates. Enterocytozoon bieneusi is the most common cause of microsporidiosis in humans, affe
Autor:
Magdalena Corona, Mayte Coiras, Daniel Podzamczer, Juan Ambrosioni, Elena Knops, Matilde Sánchez-Conde, Paula Martínez-Román, Christoph Wyen, Vicente Planelles, Adam M. Spivak, Luz Martín-Carbonero, María del Mar Díaz-Goizueta, M. Torres, Maria C. Puertas, Javier Martinez-Picado, Lorena Vigón, Christian Hoffmann, Verónica Briz, Sara Rodríguez-Mora, José Alcamí, María Rosa López-Huertas, José M. Miró, Pablo Ryan, Valentín García-Gutiérrez, Miguel Cervero, Elena Mateos, Maria Cristina O. Salgado, Antonio Navarro, Alejandro Luna de Abia
Publikováno v:
Biochem Pharmacol
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de la UB
Universidad de Barcelona
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Biochemical Pharmacology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de la UB
Universidad de Barcelona
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Biochemical Pharmacology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Factor de impacto: 5,858 Q1 The latent viral reservoir formed by HIV-1, mainly in CD4+ T cells, is responsible for the failure of antiretroviral therapy (ART) to achieve a complete elimination of the virus in infected individuals. We previously deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c379231051c08dab9dfbfcceb0247a3
https://europepmc.org/articles/PMC8478809/
https://europepmc.org/articles/PMC8478809/
Publikováno v:
Journal of Clinical Medicine
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal of Clinical Medicine, Vol 9, Iss 1607, p 1607 (2020)
Volume 9
Issue 6
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal of Clinical Medicine, Vol 9, Iss 1607, p 1607 (2020)
Volume 9
Issue 6
Background: Hepatitis C virus (HCV) infection predisposes patients to other infectious diseases, such as sepsis. We aimed to analyze epidemiological trends of sepsis-related admissions, deaths, and costs in hospital admissions with chronic hepatitis
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Hepatitis C virus (HCV) is the primary etiologic agent of liver cirrhosis or hepatocellular carcinoma. HCV elevated infection rates are mostly due to the lack of an accurate and accessible screening and diagnosis, especially in low- and middle-income
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc6e83da8c2922d5beca4b697dab8a7
http://hdl.handle.net/20.500.12105/11912
http://hdl.handle.net/20.500.12105/11912
Autor:
María Rosa López-Huertas, Mayte Coiras, Daniel Valle-Millares, Lourdes Domínguez-Domínguez, Celia Crespo-Bermejo, Sara de la Fuente-Moral, Ignacio Santos, Pablo Ryan, Paula Martínez-Román, María Luisa Gaspar, Luz Martín-Carbonero, Sonia Arca-Lafuente, Verónica Briz, Isabel Cortegano, Amanda Fernández-Rodríguez
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
E-Prints Complutense. Archivo Institucional de la UCM
instname
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2091, p 2091 (2020)
Volume 9
Issue 7
Instituto de Salud Carlos III (ISCIII)
E-Prints Complutense. Archivo Institucional de la UCM
instname
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2091, p 2091 (2020)
Volume 9
Issue 7
Coinfection with hepatitis C virus (HCV) influences HIV reservoir size. However, it is unknown whether this coinfection also induces a higher provirus transcription. Viral transcription is promoted by synergy between cellular factors such as NF-&kapp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c800d4abff7f6b91253b680a15cd0fba
http://hdl.handle.net/20.500.12105/10888
http://hdl.handle.net/20.500.12105/10888
Publikováno v:
European journal of internal medicine. 75
Objective: Analysis the epidemiological trends of hospital admissions, intra-hospital deaths, and costs related to chronic hepatitis C (CHC) taking into account four major clinical stages [compensated cirrhosis (CC), end-stage liver disease (ESLD), h
Autor:
Salvador Resino, Marta Sánchez-Carrillo, Irene Mate-Cano, Verónica Briz, Claudia Palladino, Beatriz Esteban-Cartelle
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 36:262-267
Resistance-associated substitutions (RASs) to the new HCV NS5A inhibitor elbasvir may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are no data outside clinical trials evaluating their prevalence and impact i
Autor:
Verónica Briz, Claudia Palladino, Irene Mate-Cano, Marta Sánchez-Carrillo, Mónica Gutiérrez-Rivas, María Ángeles Jiménez-Sousa, Salvador Resino, Sonia Vázquez-Morón
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports
Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are few data outside clinical trials evaluating their prevalence
Autor:
Marta Sánchez-Carrillo, Verónica Briz, Alejandro Álvaro-Meca, Salvador Resino, Irene Mate-Cano, Pablo Ryan, Asunción Díaz, Paula Martínez-Román
Publikováno v:
Ann Med
Introduction: Acute hepatitis C virus (HCV) infection (AHC) is often difficult to identify due to the lack of symptoms (around 85% of cases) [1,2]. Despite the decline of HCV transmission via blood-to-blood due to donor screening programs and a decli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704067966abe711e085b139326249be4
https://europepmc.org/articles/PMC7888801/
https://europepmc.org/articles/PMC7888801/
Autor:
Cristina Diez, María Guzmán-Fulgencio, Ana Carrero, Juan Berenguer, S. Vázquez, Verónica Briz, Francisco Tejerina, Teresa Aldámiz-Echevarría, Mónica García-Álvarez, Salvador Resino, Daniel Pineda-Tenor, María Ángeles Jiménez-Sousa
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 34:385-393
Interleukin-7 (IL-7) is a critical factor in maintaining or inducing effective antiviral CD4+ and CD8+ T-cell responses. The aim of this study was to examine the association of interleukin-7 receptor-α (IL7RA) polymorphisms with a sustained virologi